User profiles for "author:Catarina Lacerda"
Catarina Lacerda, MDCentro Hospitalar e Universitário do Porto Verified email at chporto.min-saude.pt Cited by 47 |
[HTML][HTML] Tuberculous spondylitis: A report of different clinical scenarios and literature update
C Lacerda, R Linhas, R Duarte - Case Reports in Medicine, 2017 - hindawi.com
Tuberculosis is still one of the most important health problems in the world. In developed
countries, the proportion of extrapulmonary tuberculosis cases is increasing. Nowadays …
countries, the proportion of extrapulmonary tuberculosis cases is increasing. Nowadays …
Fetomaternal hemorrhage: a clue to intraplacental choriocarcinoma and neonatal malignancy
M Simões, G Vale, C Lacerda, P Pais… - The Journal of Maternal …, 2022 - Taylor & Francis
Fetomaternal hemorrhage (FMH) is a known cause of neonatal anemia due to fetal blood
loss to the maternal circulation, occurring when the maternal-fetal barrier is disrupted …
loss to the maternal circulation, occurring when the maternal-fetal barrier is disrupted …
Pneumopericardium due to bronchopericardial fistula in a patient with lung cancer
J Lages, CC Oliveira, C Lacerda - Case Reports, 2018 - casereports.bmj.com
Documented cases of pneumopericardium in patients with lung cancer are extremely rare.
We report the case of a 66-year-old man with a 45 pack-year smoking history and an …
We report the case of a 66-year-old man with a 45 pack-year smoking history and an …
PET-CT SUVmax and Endobronchial Ultrasound Features for Prediction of Malignancy: A Prospective Study
Introduction Accurate and early staging of lung cancer has a critical impact on its prognosis.
EBUS-TBNA is often the procedure of choice for mediastinal staging. Comprehension of the …
EBUS-TBNA is often the procedure of choice for mediastinal staging. Comprehension of the …
Loop gain in heart failure with reduced ejection fraction and periodic breathing is associated with sleep stage and arousals
SD Herkenrath, C Lacerda, M Treml… - Annals of the …, 2019 - atsjournals.org
Results All patients were men, 73±5 years old (mean±SD), with a body mass index of 28±4
kg/m 2 and a left ventricular ejection fraction of 30±8%. The PSG showed severe CSA …
kg/m 2 and a left ventricular ejection fraction of 30±8%. The PSG showed severe CSA …
Thrombocytopaenia and thyroiditis: coincidence?
S Fonseca, C Lacerda, I Ganhão… - BMJ Case Reports …, 2019 - casereports.bmj.com
Thrombocytopaenia can be associated with an autoimmune mechanism. Immune
thrombocytopaenia can be associated with thyroid autoimmune disease. The authors …
thrombocytopaenia can be associated with thyroid autoimmune disease. The authors …
Secondary organizing pneumonia mimicking pulmonary metastasis of a diffuse large cell lymphoma
Secondary Organizing Pneumonia (OP) due to malignancy is a condition extremely rare. We
describe a case of a 36 years-old woman, who presented with right cervical …
describe a case of a 36 years-old woman, who presented with right cervical …
Loop Gain in Heart Failure Patients with Periodic Breathing
S Herkenrath, C Lacerda, A Castrogiovanni, M Treml… - 2017 - Eur Respiratory Soc
Introduction: Periodic Breathing (PB) is common in heart failure (HF). The loop gain (LG)
reflects the amount of instability of the respiratory control system. The LG can be quantified …
reflects the amount of instability of the respiratory control system. The LG can be quantified …
Pseudomonas aeruginosa pneumonia in the community
Introduction: The P. aeruginosa pneumonia acquired in a non-hospital environment
(Community-Acquired Pneumonia [CAP] and Healthcare-Associated Pneumonia [HCAP]) is …
(Community-Acquired Pneumonia [CAP] and Healthcare-Associated Pneumonia [HCAP]) is …
Osimertinib as a second-line treatment for EGFR-mutated non-small cell lung cancer: the experience of a pulmonology department
DDB Rodrigues, C Lacerda, F Aguiar, MJ Araújo… - 2020 - Eur Respiratory Soc
Introduction: The third-generation tyrosine kinase inhibitor (TKI) osimertinib is recommended
as first-line therapy for advanced non-small cell lung cancer (NSCLC) with epidermal growth …
as first-line therapy for advanced non-small cell lung cancer (NSCLC) with epidermal growth …